Magnesium Supplementation Attenuates Pulmonary Hypertension via Regulation of Magnesium Transporters. 2021

Dan Wang, and Zhuang-Li Zhu, and Da-Cen Lin, and Si-Yi Zheng, and Kun-Han Chuang, and Long-Xin Gui, and Ru-Hui Yao, and Wei-Jie Zhu, and James S K Sham, and Mo-Jun Lin
From the Key Laboratory of Fujian Province Universities on Ion Channel and Signal Transduction in Cardiovascular Diseases, (D.W., Z.-L.Z., D.-C.L., S.-Y.Z., K.-H.C., L.-X.G., R.-H.Y., W.-J.Z., M.-J.L.), School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.

Pulmonary hypertension (PH) is characterized by profound vascular remodeling and altered Ca2+ homeostasis in pulmonary arterial smooth muscle cells (PASMCs). Magnesium ion (Mg2+), a natural Ca2+ antagonist and a cofactor for numerous enzymes, is crucial for regulating diverse cellular functions, but its roles in PH remains unclear. Here, we examined the roles of Mg2+ and its transporters in PH development. Chronic hypoxia and monocrotaline induced significant PH in adult male rats. It was associated with a reduction of [Mg2+]i in PASMCs, a significant increase in gene expressions of Cnnm2, Hip14, Hip14l, Magt1, Mmgt1, Mrs2, Nipa1, Nipa2, Slc41a1, Slc41a2 and Trpm7; upregulation of SLC41A1, SLC41A2, CNNM2, and TRPM7 proteins; and downregulation of SLC41A3 mRNA and protein. Mg2+ supplement attenuated pulmonary arterial pressure, right heart hypertrophy, and medial wall thickening of pulmonary arteries, and reversed the changes in the expression of Mg2+ transporters. Incubation of PASMCs with a high concentration of Mg2+ markedly inhibited PASMC proliferation and migration, and increased apoptosis, whereas a low level of Mg2+ produced the opposite effects. siRNA targeting Slc41a1/2, Cnnm2, and Trpm7 attenuated PASMC proliferation and migration, but promoted apoptosis; and Slc41a3 overexpression also caused similar effects. Moreover, siRNA targeting Slc41a1 or high [Mg2+] incubation inhibited hypoxia-induced upregulation and nuclear translocation of NFATc3 in PASMCs. The results, for the first time, provide the supportive evidence that Mg2+ transporters participate in the development of PH by modulating PASMC proliferation, migration, and apoptosis; and Mg2+ supplementation attenuates PH through regulation of Mg2+ transporters involving the NFATc3 signaling pathway.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation

Related Publications

Dan Wang, and Zhuang-Li Zhu, and Da-Cen Lin, and Si-Yi Zheng, and Kun-Han Chuang, and Long-Xin Gui, and Ru-Hui Yao, and Wei-Jie Zhu, and James S K Sham, and Mo-Jun Lin
December 2002, Pediatrics international : official journal of the Japan Pediatric Society,
Dan Wang, and Zhuang-Li Zhu, and Da-Cen Lin, and Si-Yi Zheng, and Kun-Han Chuang, and Long-Xin Gui, and Ru-Hui Yao, and Wei-Jie Zhu, and James S K Sham, and Mo-Jun Lin
August 1994, Journal of applied physiology (Bethesda, Md. : 1985),
Dan Wang, and Zhuang-Li Zhu, and Da-Cen Lin, and Si-Yi Zheng, and Kun-Han Chuang, and Long-Xin Gui, and Ru-Hui Yao, and Wei-Jie Zhu, and James S K Sham, and Mo-Jun Lin
December 1988, Clinical science (London, England : 1979),
Dan Wang, and Zhuang-Li Zhu, and Da-Cen Lin, and Si-Yi Zheng, and Kun-Han Chuang, and Long-Xin Gui, and Ru-Hui Yao, and Wei-Jie Zhu, and James S K Sham, and Mo-Jun Lin
September 2006, Frontiers in bioscience : a journal and virtual library,
Dan Wang, and Zhuang-Li Zhu, and Da-Cen Lin, and Si-Yi Zheng, and Kun-Han Chuang, and Long-Xin Gui, and Ru-Hui Yao, and Wei-Jie Zhu, and James S K Sham, and Mo-Jun Lin
August 1999, American journal of hypertension,
Dan Wang, and Zhuang-Li Zhu, and Da-Cen Lin, and Si-Yi Zheng, and Kun-Han Chuang, and Long-Xin Gui, and Ru-Hui Yao, and Wei-Jie Zhu, and James S K Sham, and Mo-Jun Lin
January 2019, Frontiers in bioscience (Landmark edition),
Dan Wang, and Zhuang-Li Zhu, and Da-Cen Lin, and Si-Yi Zheng, and Kun-Han Chuang, and Long-Xin Gui, and Ru-Hui Yao, and Wei-Jie Zhu, and James S K Sham, and Mo-Jun Lin
September 2011, European journal of pharmacology,
Dan Wang, and Zhuang-Li Zhu, and Da-Cen Lin, and Si-Yi Zheng, and Kun-Han Chuang, and Long-Xin Gui, and Ru-Hui Yao, and Wei-Jie Zhu, and James S K Sham, and Mo-Jun Lin
November 2021, Biomolecules,
Dan Wang, and Zhuang-Li Zhu, and Da-Cen Lin, and Si-Yi Zheng, and Kun-Han Chuang, and Long-Xin Gui, and Ru-Hui Yao, and Wei-Jie Zhu, and James S K Sham, and Mo-Jun Lin
March 2019, American journal of hypertension,
Dan Wang, and Zhuang-Li Zhu, and Da-Cen Lin, and Si-Yi Zheng, and Kun-Han Chuang, and Long-Xin Gui, and Ru-Hui Yao, and Wei-Jie Zhu, and James S K Sham, and Mo-Jun Lin
January 2016, Przeglad lekarski,
Copied contents to your clipboard!